Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
October 29, 2009
Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma
Markus Luster, Wolfram Karges, Katrin Zeich, et al.
Cancers
|
July 29, 2023
Optimization of Radiolabeling of a [<sup>90</sup>Y]Y-Anti-CD66-Antibody for Radioimmunotherapy before Allogeneic Hematopoietic Cell Transplantation
Gordon Winter, Carmen Hamp-Goldstein, Gabriel Fischer, et al.
Thyroid : Official Journal of the American Thyroid Association
|
May 11, 2010
Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma
Markus Luster, Wolfram Karges, Katrin Zeich, et al.
Nuklearmedizin. Nuclear Medicine
|
September 5, 2025
First clinical application of silicon-based [¹⁸F]siPSMA-14 in prostate cancer patients: A proof-of-concept study
Jonathan Miksch, Elham Yousefzadeh-Nowshahr, Deni Hardiansyah, et al.
Neuroimage. Clinical
|
February 22, 2026
Advanced neuroimaging assessment of neurodegenerative dementia syndromes: A framework for comprehensive multimodal FDG-PET, MR-perfusion, and MR-diffusion analysis
Joachim Strobel, Jan Kassubek, Wolfgang Thaiss, et al.
Frontiers in Nuclear Medicine
|
October 2, 2024
Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and Trends
Claus Zippel, Johannes Ermert, Marianne Patt, et al.
EJNMMI Research
|
October 1, 2022
Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225
Catherine Meyer, Vikas Prasad, Andreea Stuparu, et al.
Neuroimage
|
November 24, 2007
[11C]PIB binding in Parkinson's disease dementia
Walter Maetzler, Matthias Reimold, Inga Liepelt, et al.
Nanomaterials (Basel, Switzerland)
|
December 23, 2022
Preclinical PET and MR Evaluation of <sup>89</sup>Zr- and <sup>68</sup>Ga-Labeled Nanodiamonds in Mice over Different Time Scales
Gordon Winter, Nina Eberhardt, Jessica Löffler, et al.
Plos One
|
April 11, 2022
Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting
Elham Yousefzadeh-Nowshahr, Gordon Winter, Peter Bohn, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
European Journal of Nuclear Medicine and Molecular Imaging
|
October 29, 2009
Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma
Markus Luster, Wolfram Karges, Katrin Zeich, et al.
Cancers
|
July 29, 2023
Optimization of Radiolabeling of a [<sup>90</sup>Y]Y-Anti-CD66-Antibody for Radioimmunotherapy before Allogeneic Hematopoietic Cell Transplantation
Gordon Winter, Carmen Hamp-Goldstein, Gabriel Fischer, et al.
Thyroid : Official Journal of the American Thyroid Association
|
May 11, 2010
Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma
Markus Luster, Wolfram Karges, Katrin Zeich, et al.
Nuklearmedizin. Nuclear Medicine
|
September 5, 2025
First clinical application of silicon-based [¹⁸F]siPSMA-14 in prostate cancer patients: A proof-of-concept study
Jonathan Miksch, Elham Yousefzadeh-Nowshahr, Deni Hardiansyah, et al.
Neuroimage. Clinical
|
February 22, 2026
Advanced neuroimaging assessment of neurodegenerative dementia syndromes: A framework for comprehensive multimodal FDG-PET, MR-perfusion, and MR-diffusion analysis
Joachim Strobel, Jan Kassubek, Wolfgang Thaiss, et al.
Frontiers in Nuclear Medicine
|
October 2, 2024
Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and Trends
Claus Zippel, Johannes Ermert, Marianne Patt, et al.
EJNMMI Research
|
October 1, 2022
Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225
Catherine Meyer, Vikas Prasad, Andreea Stuparu, et al.
Neuroimage
|
November 24, 2007
[11C]PIB binding in Parkinson's disease dementia
Walter Maetzler, Matthias Reimold, Inga Liepelt, et al.
Nanomaterials (Basel, Switzerland)
|
December 23, 2022
Preclinical PET and MR Evaluation of <sup>89</sup>Zr- and <sup>68</sup>Ga-Labeled Nanodiamonds in Mice over Different Time Scales
Gordon Winter, Nina Eberhardt, Jessica Löffler, et al.
Plos One
|
April 11, 2022
Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting
Elham Yousefzadeh-Nowshahr, Gordon Winter, Peter Bohn, et al.
Page
of 4